Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

exponent inc. - EXPO

EXPO

Close Chg Chg %
70.83 8.96 12.65%

Closed Market

79.79

+8.96 (12.65%)

Volume: 940.70K

Last Updated:

Feb 6, 2026, 4:00 PM EDT

Trade Now

Company Overview: exponent inc. - EXPO

EXPO Key Data

Open

$72.65

 Day Range

72.00 - 80.60

52 Week Range

63.81 - 97.57

 Market Cap

$3.50B

Shares Outstanding

49.89M

 Public Float

49.36M

Beta

0.80

 Rev. Per Employee

N/A

P/E Ratio

34.22

 EPS

$2.08

Yield

169.42%

 Dividend

$0.30

EX-DIVIDEND DATE

Dec 5, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

374.40K

  

EXPO Performance

1 Week
 
 11.02%
 
1 Month
 
 6.97%
 
3 Months
 
 13.07%
 
1 Year
 
 -12.22%
 
5 Years
 
 -11.10%
 

EXPO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 5
Full Ratings ➔

About exponent inc. - EXPO

Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. It operates through the Engineering and Other Scientific, and Environmental and Health segments. The Engineering and Other Scientific segment includes technical consulting in different practices primarily in engineering. The Environmental and Health segment offers services in environmental, epidemiology, and health risk analysis. The company was founded by Bernard Ross in 1967 and is headquartered in Menlo Park, CA.

EXPO At a Glance

Exponent, Inc.
149 Commonwealth Drive
Menlo Park, California 94025
Phone 1-650-326-9400 Revenue 558.51M
Industry Engineering & Construction Net Income 109.00M
Sector Industrial Services 2024 Sales Growth 4.052%
Fiscal Year-end 12 / 2025 Employees 1,168
View SEC Filings

EXPO Valuation

P/E Current 34.217
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 42.064
Price to Sales Ratio 8.209
Price to Book Ratio 10.73
Price to Cash Flow Ratio 31.72
Enterprise Value to EBITDA 34.102
Enterprise Value to Sales 7.892
Total Debt to Enterprise Value 0.018

EXPO Efficiency

Revenue/Employee 478,179.795
Income Per Employee 93,323.63
Receivables Turnover 3.46
Total Asset Turnover 0.759

EXPO Liquidity

Current Ratio 2.739
Quick Ratio 2.739
Cash Ratio 1.587

EXPO Profitability

Gross Margin 25.475
Operating Margin 21.406
Pretax Margin 26.386
Net Margin 19.516
Return on Assets 14.817
Return on Equity 28.052
Return on Total Capital 21.69
Return on Invested Capital 24.909

EXPO Capital Structure

Total Debt to Total Equity 19.35
Total Debt to Total Capital 16.213
Total Debt to Total Assets 10.072
Long-Term Debt to Equity 18.069
Long-Term Debt to Total Capital 15.14
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Exponent Inc. - EXPO

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
466.27M 513.29M 536.77M 558.51M
Sales Growth
+16.60% +10.09% +4.57% +4.05%
Cost of Goods Sold (COGS) incl D&A
342.06M 348.79M 401.00M 416.23M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
6.49M 7.08M 8.92M 9.69M
Depreciation
6.49M 7.08M 8.92M 9.69M
Amortization of Intangibles
- - - -
-
COGS Growth
+12.61% +1.97% +14.97% +3.80%
Gross Income
124.21M 164.50M 135.76M 142.28M
Gross Income Growth
+29.20% +32.44% -17.47% +4.80%
Gross Profit Margin
+26.64% +32.05% +25.29% +25.48%
2021 2022 2023 2024 5-year trend
SG&A Expense
15.28M 23.66M 24.44M 22.73M
Research & Development
- - - -
-
Other SG&A
15.28M 23.66M 24.44M 22.73M
SGA Growth
+18.58% +54.82% +3.30% -7.01%
Other Operating Expense
- - - -
-
Unusual Expense
(14.73M) 14.19M (14.31M) (14.93M)
EBIT after Unusual Expense
123.66M 126.66M 125.64M 134.49M
Non Operating Income/Expense
2.18M 5.58M 10.26M 12.88M
Non-Operating Interest Income
66.00K 2.10M 7.15M 10.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
125.84M 132.23M 135.90M 147.37M
Pretax Income Growth
+29.81% +5.08% +2.77% +8.44%
Pretax Margin
+26.99% +25.76% +25.32% +26.39%
Income Tax
24.64M 29.90M 35.56M 38.37M
Income Tax - Current - Domestic
28.39M 35.29M 33.22M 38.63M
Income Tax - Current - Foreign
2.25M 1.97M 2.25M 3.04M
Income Tax - Deferred - Domestic
(6.00M) (7.36M) 85.00K (3.30M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
101.20M 102.33M 100.34M 109.00M
Minority Interest Expense
- - - -
-
Net Income
101.20M 102.33M 100.34M 109.00M
Net Income Growth
+22.59% +1.11% -1.95% +8.63%
Net Margin Growth
+21.70% +19.94% +18.69% +19.52%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
101.20M 102.33M 100.34M 109.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
101.20M 102.33M 100.34M 109.00M
EPS (Basic)
1.9236 1.9783 1.9616 2.1319
EPS (Basic) Growth
+22.07% +2.84% -0.84% +8.68%
Basic Shares Outstanding
52.61M 51.73M 51.15M 51.13M
EPS (Diluted)
1.8976 1.9574 1.9432 2.1137
EPS (Diluted) Growth
+22.57% +3.15% -0.73% +8.77%
Diluted Shares Outstanding
53.33M 52.28M 51.63M 51.57M
EBITDA
115.41M 147.92M 120.24M 129.25M
EBITDA Growth
+28.07% +28.17% -18.71% +7.49%
EBITDA Margin
+24.75% +28.82% +22.40% +23.14%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 85.50
Number of Ratings 5 Current Quarters Estimate 0.567
FY Report Date 03 / 2026 Current Year's Estimate 2.26
Last Quarter’s Earnings 0.49 Median PE on CY Estimate N/A
Year Ago Earnings 2.07 Next Fiscal Year Estimate 2.488
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 4 4
Mean Estimate 0.57 0.57 2.26 2.49
High Estimates 0.57 0.58 2.30 2.58
Low Estimate 0.56 0.55 2.23 2.38
Coefficient of Variance 1.04 2.37 1.40 3.75

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 2
OVERWEIGHT 1 1 1
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Exponent Inc. - EXPO

Date Name Shares Transaction Value
Jun 11, 2025 Carol Lindstrom Director 7,396 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 11, 2025 Carol Lindstrom Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 11, 2025 Carol Lindstrom Director 2,009 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 17, 2025 Joseph Sala Group Vice President N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Richard L. Schlenker EVP & Chief Financial Officer 224,700 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Maureen Reitman Group Vice President 35,612 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $82.33 per share 2,931,935.96
Mar 17, 2025 Maureen Reitman Group Vice President 36,802 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Bradley A. James Group Vice President N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Bradley A. James Group Vice President 2,694 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $82.33 per share 221,797.02
Mar 17, 2025 Bradley A. James Group Vice President 4,046 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Richard Reiss Group Vice President N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Richard Reiss Group Vice President 2,798 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $82.33 per share 230,359.34
Mar 17, 2025 Richard Reiss Group Vice President 3,622 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 John D. Pye Group Vice President N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 John D. Pye Group Vice President 31,204 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $82.33 per share 2,569,025.32
Mar 17, 2025 John D. Pye Group Vice President 32,070 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Catherine Ford Corrigan President & CEO; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Catherine Ford Corrigan President & CEO; Director 81,342 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $82.33 per share 6,696,886.86
Mar 17, 2025 Catherine Ford Corrigan President & CEO; Director 84,967 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 17, 2025 Richard L. Schlenker EVP & Chief Financial Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Exponent Inc. in the News